The SCOTUS decision preserves free preventive health care and sets the stage for a bigger role for RFK Jr. in determining ...

NIH has made no progress in narrowing the funding gap created by the freeze on grant approvals despite resuming grant review ...

A federal judge ruled that the government did not violate the law in a dispute with J&J over the 340B drug discount program.

Amid ongoing controversy, U.S. Sen. Maggie Hassan (D-N.H.) is investigating GSK for replacing a popular asthma inhaler with a ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

An WHO expert group investigating how the Covid-19 pandemic started released its final report, reaching an unsatisfying ...

Proposed cuts will have “a catastrophic effect on the advancement of biomedical and biotechnology capabilities in the United ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

STAT readers cheer and criticize recent First Opinion essays on organ donation complications, research funding, and more.

We cannot and will not gamble with our patients’ health or the health of our communities,” write the presidents of the AAFP, ...

It’s deadline day for autism researchers to submit a research proposal to the Autism Data Science Initiative at the NIH. The ...

The ACIP, the CDC’s vaccine advisory panel newly empowered by health secretary Robert F. Kennedy Jr., is just getting started ...